Taken together, the data establish that genetic deletion of Gpr35 worsens key PD-related phenotypes in the MPTP model, particularly affecting motor performance, survival of dopaminergic neurons, and the progression of neuroinflammation. Here, GPR35 is linked to Parkinson disease.